Cargando…

Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial

BACKGROUND: Tobacco smoking remains one of the biggest public health threats. Smartphone apps offer new promising opportunities for supporting smoking cessation in real-time. The social context of smokers has, however, been neglected in smartphone apps promoting smoking cessation. This randomized co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lüscher, Janina, Berli, Corina, Schwaninger, Philipp, Scholz, Urte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819348/
https://www.ncbi.nlm.nih.gov/pubmed/31664959
http://dx.doi.org/10.1186/s12889-019-7723-z
_version_ 1783463708138143744
author Lüscher, Janina
Berli, Corina
Schwaninger, Philipp
Scholz, Urte
author_facet Lüscher, Janina
Berli, Corina
Schwaninger, Philipp
Scholz, Urte
author_sort Lüscher, Janina
collection PubMed
description BACKGROUND: Tobacco smoking remains one of the biggest public health threats. Smartphone apps offer new promising opportunities for supporting smoking cessation in real-time. The social context of smokers has, however, been neglected in smartphone apps promoting smoking cessation. This randomized controlled trial investigates the effectiveness of a smartphone app in which smokers quit smoking with the help of a social network member. METHODS: This protocol describes the design of a single-blind, two-arm, parallel-group, intensive longitudinal randomized controlled trial. Participants of this study are adult smokers who smoke at least one cigarette per day and intend to quit smoking at a self-set quit date. Blocking as means of group-balanced randomization is used to allocate participants to intervention or control conditions. Both intervention and control group use a smartphone-compatible device for measuring their daily smoking behavior objectively via exhaled carbon monoxide. In addition, the intervention group is instructed to use the SmokeFree Buddy app, a multicomponent app that also facilitates smoking-cessation specific social support from a buddy over a smartphone application. All participants fill out a baseline diary for three consecutive days and are invited to the lab for a background assessment. They subsequently participate in an end-of-day diary phase from 7 days before and until 20 days after a self-set quit date. Six months after the self-set quit date a follow-up diary for three consecutive days takes place. The primary outcome measures are daily self-reported and objectively-assessed smoking abstinence and secondary outcome measures are daily self-reported number of cigarettes smoked. DISCUSSION: This is the first study examining the effectiveness of a smoking cessation mobile intervention using the SmokeFree Buddy app compared to a control group in a real-life setting around a self-set quit date using a portable objective measure to assess smoking abstinence. Opportunities and challenges with running studies with smoking participants and certain design-related decisions are discussed. TRIAL REGISTRATION: This trial was prospectively registered on 04/04/2018 at ISRCTNregistry: ISRCTN11154315.
format Online
Article
Text
id pubmed-6819348
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68193482019-10-31 Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial Lüscher, Janina Berli, Corina Schwaninger, Philipp Scholz, Urte BMC Public Health Study Protocol BACKGROUND: Tobacco smoking remains one of the biggest public health threats. Smartphone apps offer new promising opportunities for supporting smoking cessation in real-time. The social context of smokers has, however, been neglected in smartphone apps promoting smoking cessation. This randomized controlled trial investigates the effectiveness of a smartphone app in which smokers quit smoking with the help of a social network member. METHODS: This protocol describes the design of a single-blind, two-arm, parallel-group, intensive longitudinal randomized controlled trial. Participants of this study are adult smokers who smoke at least one cigarette per day and intend to quit smoking at a self-set quit date. Blocking as means of group-balanced randomization is used to allocate participants to intervention or control conditions. Both intervention and control group use a smartphone-compatible device for measuring their daily smoking behavior objectively via exhaled carbon monoxide. In addition, the intervention group is instructed to use the SmokeFree Buddy app, a multicomponent app that also facilitates smoking-cessation specific social support from a buddy over a smartphone application. All participants fill out a baseline diary for three consecutive days and are invited to the lab for a background assessment. They subsequently participate in an end-of-day diary phase from 7 days before and until 20 days after a self-set quit date. Six months after the self-set quit date a follow-up diary for three consecutive days takes place. The primary outcome measures are daily self-reported and objectively-assessed smoking abstinence and secondary outcome measures are daily self-reported number of cigarettes smoked. DISCUSSION: This is the first study examining the effectiveness of a smoking cessation mobile intervention using the SmokeFree Buddy app compared to a control group in a real-life setting around a self-set quit date using a portable objective measure to assess smoking abstinence. Opportunities and challenges with running studies with smoking participants and certain design-related decisions are discussed. TRIAL REGISTRATION: This trial was prospectively registered on 04/04/2018 at ISRCTNregistry: ISRCTN11154315. BioMed Central 2019-10-29 /pmc/articles/PMC6819348/ /pubmed/31664959 http://dx.doi.org/10.1186/s12889-019-7723-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Lüscher, Janina
Berli, Corina
Schwaninger, Philipp
Scholz, Urte
Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
title Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
title_full Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
title_fullStr Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
title_full_unstemmed Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
title_short Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
title_sort smoking cessation with smartphone applications (swapp): study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819348/
https://www.ncbi.nlm.nih.gov/pubmed/31664959
http://dx.doi.org/10.1186/s12889-019-7723-z
work_keys_str_mv AT luscherjanina smokingcessationwithsmartphoneapplicationsswappstudyprotocolforarandomizedcontrolledtrial
AT berlicorina smokingcessationwithsmartphoneapplicationsswappstudyprotocolforarandomizedcontrolledtrial
AT schwaningerphilipp smokingcessationwithsmartphoneapplicationsswappstudyprotocolforarandomizedcontrolledtrial
AT scholzurte smokingcessationwithsmartphoneapplicationsswappstudyprotocolforarandomizedcontrolledtrial